Health-care companies fell sharply amid regulatory concerns. AstraZeneca plans a new investment of $2 billion in the U.S., one of the first major foreign companies to shift spending to the country ...

Welcome to the Regulatory Roundup. Each month, Eversheds Sutherland Investment Services attorneys review significant regulatory developments (including notable rulemakings and guidance from securities ...

A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers ...

Bitcoin hit another high Monday, as the rally in cryptocurrencies continued following President-elect Donald Trump's election ...

“Despite beating revenue estimates in Q1, SMCI faces significant regulatory concerns ... growth from AI would be wise to look elsewhere for companies that do not show signs of reputational hazard ...

In 2016, Trump famously scorned California for wasting water by allowing its major rivers to reach the ocean. More recently, ...

Tennessee voters trust Donald Trump more with the economy and their pocketbooks than the Biden-Harris Administration.

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our ... radiation safety infrastructure across the region. With a robust regulatory infrastructure in ...

Genome-wide analysis of miRNA co-expression and co-targeting networks at distinct developmental stages sheds light into the regulatory role of miRNAs in shaping the development of the embryonic ...

General Catalyst’s Health Transformation Company has signed a definitive agreement to buy Summa Health for $485 million, the ...

With Trump, tariffs are likely to be a headache, tax cuts could be a tailwind, and an immigration crackdown may make hiring ...